Article info
Poster Presentations
Rheumatoid arthritis - prognosis, predictors and outcome
FRI0089 C4M – A Blood-Based Biomarker – Is An Objective Marker of Disease Activity and Radiographic Status: Replication and Validation or Previous Findings in The Oskira Rheumatoid Arthritis Studies
Citation
FRI0089 C4M – A Blood-Based Biomarker – Is An Objective Marker of Disease Activity and Radiographic Status: Replication and Validation or Previous Findings in The Oskira Rheumatoid Arthritis Studies
Publication history
- First published July 15, 2016.
Online issue publication
July 15, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions